NCT05555680 2025-12-09
HIP
Clinique Ovo
Terminated
Clinical Trials
5 trialsNCT05370521 2025-10-09
A Study of Safety and Efficacy of Tildacerfont in Females With Polycystic Ovary Syndrome and Elevated Adrenal Androgens
Spruce Biosciences
Phase 2 Terminated
NCT02865915 2021-02-01
MLE4901 vs. Placebo for the Treatment of PCOS
Millendo Therapeutics, Inc.
Phase 2 Terminated
NCT03119077 2018-05-17
Single Ascending Dose, First-in-Human Study on Safety, Tolerability and Pharmacokinetics of BAY1161116
Bayer
Phase 1 Terminated
NCT01969396 2014-12-23
Evaluation of the Goldstein SonoBiopsyâ„¢ Catheter for Diagnosing Endometrial Pathology
Cook Group Incorporated
Phase NA Terminated